Report examines strategies for reducing breast cancer risk.
Miller
J L
JL
D001943:Breast Neoplasms / Q000517:prevention & control*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D012306:Risk
D004965:Estrogen Antagonists; D020849:Raloxifene Hydrochloride